Sun Zhe, Liu Lu, Liu Hongbing, Luo Fang
Department of Day Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
J Pain Res. 2023 Mar 21;16:1005-1015. doi: 10.2147/JPR.S395420. eCollection 2023.
To evaluate the effectiveness and safety of CT-guided radiofrequency thermocoagulation (RFT) for the treatment of infraorbital neuralgia following the failure of conservative management.
This was a single center, retrospective study which included 196 patients between the ages of 37 to 90 years, who suffered from infraorbital neuralgia, and had undergone CT-guided RFT treatment. The medical records of these patients were retrieved between January 7, 2015 and February 5, 2020, and the patients were followed up for 2 years. Follow-up outcomes included Numerical Rating Scale (NRS) scores, dosage of carbamazepine, time to take effect, status of recurrence and side effects. The effective rate was defined as the percentage of patients with postoperative NRS score reduction of >50%.
The effective rates were 92.9%, 100%, 100%, 100%, 93.4% and 85.7% on the same day, week 1, month 1, month 6, year 1 and year 2 after RFT, respectively. After RFT, the postoperative NRS scores and dosage of carbamazepine were significantly reduced than those preoperatively (P < 0.05). The median time to take effect was zero day. Twenty-eight patients with recurrence underwent RFT again and achieved complete pain relief. All patients experienced numbness in the infraorbital nerve innervation area and the numbness scores gradually decreased over time.
CT-guided RFT treatment may be an effective and safe technique for pain relief in patients with infraorbital neuralgia following failed results from conservative treatment.
评估CT引导下射频热凝术(RFT)治疗保守治疗失败后的眶下神经痛的有效性和安全性。
这是一项单中心回顾性研究,纳入了196例年龄在37至90岁之间、患有眶下神经痛且接受了CT引导下RFT治疗的患者。于2015年1月7日至2020年2月5日期间检索这些患者的病历,并对患者进行了2年的随访。随访结果包括数字评定量表(NRS)评分、卡马西平用量、起效时间、复发情况及副作用。有效率定义为术后NRS评分降低>50%的患者百分比。
RFT后当天、第1周、第1个月、第6个月、第1年和第2年的有效率分别为92.9%、100%、100%、100%、93.4%和85.7%。RFT后,术后NRS评分和卡马西平用量均较术前显著降低(P<0.05)。中位起效时间为0天。28例复发患者再次接受RFT治疗并实现了疼痛完全缓解。所有患者眶下神经支配区域均出现麻木,且麻木评分随时间逐渐降低。
对于保守治疗效果不佳的眶下神经痛患者,CT引导下RFT治疗可能是一种有效且安全的缓解疼痛的技术。